Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4854188 | 0.93 | PPARG (0.72) | PPARGPPARA | |
| SCHEMBL4854260 | 0.92 | PPARG (0.70) | PPARGPPARA | |
| SCHEMBL13718226 | 0.91 | PPARG (1.00) | PPARGPPARA | |
| SCHEMBL4846734 | 0.90 | PPARG (0.82) | PPARGPPARA | |
| SCHEMBL4848994 | 0.90 | PPARG (0.67) | PPARGPPARA | |
| SCHEMBL4852323 | 0.89 | PPARG (0.67) | PPARGPPARA | |
| SCHEMBL13717465 | 0.89 | PPARG (1.00) | PPARGPPARA | |
| SCHEMBL6624241 | 0.89 | PPARG (0.66) | PPARGPPARA | |
| SCHEMBL6622864 | 0.89 | PPARG (0.66) | PPARGPPARA | |
| SCHEMBL4852327 | 0.88 | PPARG (0.65) | PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040254370-A1 | Carboxylic acid derivatives compounds and agents comprising the compounds as active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2004-12-16 | — | — | US | claimed |
| EP-1445256-A1 | CARBOXYLIC ACID DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2004-08-11 | — | — | EP | claimed |
| US-7323456-B2 | Carboxylic acid derivatives compounds and agents comprising the compounds as active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2008-01-29 | — | — | US | disclosed |
| US-7323456-B2 | Carboxylic acid derivatives compounds and agents comprising the compounds as active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2008-01-29 | — | — | US | disclosed |
| US-7323456-B2 | Carboxylic acid derivatives compounds and agents comprising the compounds as active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2008-01-29 | — | — | US | disclosed |
| US-20040254370-A1 | Carboxylic acid derivatives compounds and agents comprising the compounds as active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2004-12-16 | — | — | US | disclosed |
| EP-1445256-A1 | CARBOXYLIC ACID DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2004-08-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040254370-A1 | Carboxylic acid derivatives compounds and agents comprising the compounds as active ingredient | SREBF1, GPR119, PPARG | PPARG 3/4885PPARA 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.